In prior studies, investigators had identified significant associations between serum NSE and clinical stage and tumor size in patients with tumors, with higher serum NSE commonly observed in patients with advanced stage and larger tumor size (Georgantzi et al., 2018; Luo et al., 2020). This evidence concerns the gene ENO2 and neoplasm.